These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8819522)

  • 1. The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.
    Turner CR; Cohan VL; Cheng JB; Showell HJ; Pazoles CJ; Watson JW
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1349-55. PubMed ID: 8819522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
    Wright KF; Turner CR; Jayasinghe-Beck R; Cohen VL; Cheng JB; Watson JW
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1001-8. PubMed ID: 9360015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.
    Underwood DC; Bochnowicz S; Osborn RR; Kotzer CJ; Luttmann MA; Hay DW; Gorycki PD; Christensen SB; Torphy TJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):988-95. PubMed ID: 9864284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].
    Boswell-Smith V; Spina D; Oxford AW; Comer MB; Seeds EA; Page CP
    J Pharmacol Exp Ther; 2006 Aug; 318(2):840-8. PubMed ID: 16682455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin.
    Lü HJ; Qiu ZM; Wei WL; Yu L; Liu RL; Zhang M
    Chin Med J (Engl); 2004 Nov; 117(11):1620-4. PubMed ID: 15569475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
    Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
    Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
    Cheng JB; Pillar JS; Shirley JT; Showell HJ; Watson JW; Cohan VL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):922-9. PubMed ID: 8437132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of cryptoporus polysaccharide on airway constriction, eosinophil release, and chemotaxis in guinea pigs.
    Zhao XY; Xie QM; Chen JQ; Ke CK
    Acta Pharmacol Sin; 2004 Apr; 25(4):503-7. PubMed ID: 15066221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
    Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.
    Murray KJ; Eden RJ; England PJ; Dolan J; Grimsditch DC; Stutchbury CA; Patel B; Reeves ML; Worby A; Torphy TJ
    Agents Actions Suppl; 1991; 34():27-46. PubMed ID: 1665307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs.
    Aoki M; Yamamoto S; Kobayashi M; Ohga K; Kanoh H; Miyata K; Honda K; Yamada T
    J Pharmacol Exp Ther; 2001 Apr; 297(1):165-73. PubMed ID: 11259541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
    Danahay H; Broadley KJ
    Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.